A Clinical and Genetic Evaluation of Cases with Folate Receptor α Gene Mutation: A Case Series from Türkiye
<b>Background/Objectives</b>: Cerebral folate transporter deficiency is characterized by pauses and regression in general development stages, with ataxia, choreoathetoid movements, and myoclonic epilepsy generally resistant to treatment. The aim of this study was to comprehensively evalu...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/7/892 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850213132990939136 |
|---|---|
| author | Abdurrahman Akgun Ibrahim Tas |
| author_facet | Abdurrahman Akgun Ibrahim Tas |
| author_sort | Abdurrahman Akgun |
| collection | DOAJ |
| description | <b>Background/Objectives</b>: Cerebral folate transporter deficiency is characterized by pauses and regression in general development stages, with ataxia, choreoathetoid movements, and myoclonic epilepsy generally resistant to treatment. The aim of this study was to comprehensively evaluate cases followed up in two centres in Türkiye for a diagnosis of folate receptor-α deficiency. <b>Methods</b>: The study included nine cases from six different families. <b>Results</b>: The patients comprised 22.2% males and there was parental consanguinity in 88.9% of cases. The mean age at which complaints were first noticed was 3.7 years, and the age of definitive diagnosis was 10.4 years. The most frequently seen first complaints were febrile convulsions and attention deficit-hyperactivity-learning difficulties. The diagnosis most commonly made before the definitive diagnosis was epilepsy, and the first seizure occurred at a mean of 5.2 years. On cranial imaging, white matter involvement, cerebellar atrophy and cerebral atrophy were determined most often. Definitive diagnosis was established solely through clinical findings and genetic analysis. Three different variants in the <i>FOLR1</i> gene were determined. Treatment with folinic acid at a dose of 5.2 mg/kg/day of PO was started at the age of 9.8 years on average, and intravenous folinate was started at different doses. <b>Conclusions</b>: This study stands out as one of the largest case series in the literature and identifies a previously unreported novel variant. Our study suggests that FOLR1-related CFD should be considered in cases with febrile convulsions, developmental delay, ataxia, autism spectrum disorder, acquired microcephaly, and MRI findings of white matter involvement and cerebellar atrophy. Due to an asymptomatic early period, CFD diagnosis may be delayed, and treatment after symptom onset may be less effective. Incorporating <i>FOLR1</i> gene analysis into newborn screening programmes could facilitate early diagnosis and treatment. It is thought that the application of vagus nerve stimulation, in addition to folinic acid and anticonvulsant drug treatment, could be effective in seizure control. |
| format | Article |
| id | doaj-art-9e51cc3f25c2416e9a9b00bbb8e1eda6 |
| institution | OA Journals |
| issn | 2075-4418 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Diagnostics |
| spelling | doaj-art-9e51cc3f25c2416e9a9b00bbb8e1eda62025-08-20T02:09:11ZengMDPI AGDiagnostics2075-44182025-04-0115789210.3390/diagnostics15070892A Clinical and Genetic Evaluation of Cases with Folate Receptor α Gene Mutation: A Case Series from TürkiyeAbdurrahman Akgun0Ibrahim Tas1Division of Metabolism, Department of Pediatrics, Firat University School of Medicine, 23200 Elazig, TürkiyeClinic of Pediatric Metabolic Diseases, Umraniye Training and Research Hospital, University of Health Sciences, 34766 Istanbul, Türkiye<b>Background/Objectives</b>: Cerebral folate transporter deficiency is characterized by pauses and regression in general development stages, with ataxia, choreoathetoid movements, and myoclonic epilepsy generally resistant to treatment. The aim of this study was to comprehensively evaluate cases followed up in two centres in Türkiye for a diagnosis of folate receptor-α deficiency. <b>Methods</b>: The study included nine cases from six different families. <b>Results</b>: The patients comprised 22.2% males and there was parental consanguinity in 88.9% of cases. The mean age at which complaints were first noticed was 3.7 years, and the age of definitive diagnosis was 10.4 years. The most frequently seen first complaints were febrile convulsions and attention deficit-hyperactivity-learning difficulties. The diagnosis most commonly made before the definitive diagnosis was epilepsy, and the first seizure occurred at a mean of 5.2 years. On cranial imaging, white matter involvement, cerebellar atrophy and cerebral atrophy were determined most often. Definitive diagnosis was established solely through clinical findings and genetic analysis. Three different variants in the <i>FOLR1</i> gene were determined. Treatment with folinic acid at a dose of 5.2 mg/kg/day of PO was started at the age of 9.8 years on average, and intravenous folinate was started at different doses. <b>Conclusions</b>: This study stands out as one of the largest case series in the literature and identifies a previously unreported novel variant. Our study suggests that FOLR1-related CFD should be considered in cases with febrile convulsions, developmental delay, ataxia, autism spectrum disorder, acquired microcephaly, and MRI findings of white matter involvement and cerebellar atrophy. Due to an asymptomatic early period, CFD diagnosis may be delayed, and treatment after symptom onset may be less effective. Incorporating <i>FOLR1</i> gene analysis into newborn screening programmes could facilitate early diagnosis and treatment. It is thought that the application of vagus nerve stimulation, in addition to folinic acid and anticonvulsant drug treatment, could be effective in seizure control.https://www.mdpi.com/2075-4418/15/7/892cerebral folate transporter deficiencyFOLR15-methyltetrahydrofolatefolic acidfolinic acid |
| spellingShingle | Abdurrahman Akgun Ibrahim Tas A Clinical and Genetic Evaluation of Cases with Folate Receptor α Gene Mutation: A Case Series from Türkiye Diagnostics cerebral folate transporter deficiency FOLR1 5-methyltetrahydrofolate folic acid folinic acid |
| title | A Clinical and Genetic Evaluation of Cases with Folate Receptor α Gene Mutation: A Case Series from Türkiye |
| title_full | A Clinical and Genetic Evaluation of Cases with Folate Receptor α Gene Mutation: A Case Series from Türkiye |
| title_fullStr | A Clinical and Genetic Evaluation of Cases with Folate Receptor α Gene Mutation: A Case Series from Türkiye |
| title_full_unstemmed | A Clinical and Genetic Evaluation of Cases with Folate Receptor α Gene Mutation: A Case Series from Türkiye |
| title_short | A Clinical and Genetic Evaluation of Cases with Folate Receptor α Gene Mutation: A Case Series from Türkiye |
| title_sort | clinical and genetic evaluation of cases with folate receptor α gene mutation a case series from turkiye |
| topic | cerebral folate transporter deficiency FOLR1 5-methyltetrahydrofolate folic acid folinic acid |
| url | https://www.mdpi.com/2075-4418/15/7/892 |
| work_keys_str_mv | AT abdurrahmanakgun aclinicalandgeneticevaluationofcaseswithfolatereceptoragenemutationacaseseriesfromturkiye AT ibrahimtas aclinicalandgeneticevaluationofcaseswithfolatereceptoragenemutationacaseseriesfromturkiye AT abdurrahmanakgun clinicalandgeneticevaluationofcaseswithfolatereceptoragenemutationacaseseriesfromturkiye AT ibrahimtas clinicalandgeneticevaluationofcaseswithfolatereceptoragenemutationacaseseriesfromturkiye |